Epipen Parent's Faceplant Is a Cautionary Tale for Botox Maker

Bookmark
(Bloomberg Opinion) -- Drugmakers Mylan NV and Allergan Inc. reported first-quarter earnings Tuesday, and their results had something in common:  they both got panned by investors.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.